#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Charles J. Dockendorff joins Haemonetics board

Share on Twitter Share on LinkedIn
Staff writer | Braintree, Mass., USA | July 24, 2014
Charles J. DockendorffJuly 24, 2014, Braintree, Mass., USA - Haemonetics Corporation announced that Charles J. Dockendorff was elected to the board of directors.
Mr. Dockendorff is Executive Vice President and Chief Financial Officer with Covidien PLC, a position he has held since 1995.

Mr. Dockendorff joined Kendall Healthcare Products Company, the foundation of Covidien formerly known as Tyco Healthcare, in 1989 as Controller and he was named Vice President and Controller in 1994. He was appointed CFO of Covidien 1995.

Before joining Covidien and its predecessors, Mr. Dockendorff was CFO, Vice President of Finance and Treasurer of Epsco, Inc. and the CFO of Infrared Industries, Inc.

His early career included accounting positions with Arthur Young & Company (now Ernst & Young) and General Motors Corporation.

Mr. Dockendorff is a CPA and has a Bachelor's degree in Business Administration/Accounting from the University of Massachusetts and a Master of Science degree in Finance from Bentley College.


 LATEST MOVES FROM Massachusetts 


MORE INSIDE POST